# Drug Utilization Study for Pirinase Hayfever Relief

> **NCT02856282** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 46 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

## Key facts

- **NCT ID:** NCT02856282
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-15
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856282, "Drug Utilization Study for Pirinase Hayfever Relief". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02856282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*